The National Medicines Policy review has been restarted but the 'expert committee' that oversaw the first stalled process has been discontinued while an updated revised document now includes a vision statement.
Will restarted NMP review be better than the first attempt?
August 18, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
US FDA grants conditional approval to the brand name of Dimerix's DMX-200
September 25, 2023 - - Australian Biotech -
Budget outcome confirms double-digit growth for pharmaceutical spend
September 25, 2023 - - Latest News -
These major processes related to public health programs can not continue in this way
September 25, 2023 - - Latest News -
Hospital pharmacy launches new professional recognition program
September 25, 2023 - - Latest News -
The 'Week in Review' Podcast - 22 September
September 22, 2023 - - Podcast -
National and Labour commit to addressing Pharmac's fiscal 'cliff'
September 22, 2023 - - Latest News -
Moderna launches 'Welcome to the mRNAge' brand campaign
September 22, 2023 - - Latest News